Impact of Apolipoprotein E ε4 in Alzheimer's Disease: Insights From a Meta-Analysis.
作者信息
Kwon Hyuk Sung, Koh Seong-Ho
机构信息
Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
Department of Translational Medicine, Hanyang University Graduate School of Biomedical Science & Engineering, Seoul, Korea.
出版信息
J Clin Neurol. 2024 Sep;20(5):467-468. doi: 10.3988/jcn.2024.0353.
Abstract
摘要
相似文献
1
Impact of Apolipoprotein E ε4 in Alzheimer's Disease: Insights From a Meta-Analysis.
J Clin Neurol. 2024 Sep;20(5):467-468. doi: 10.3988/jcn.2024.0353.
2
Apolipoprotein E ε4 allele and malondialdehyde level are independent risk factors for Alzheimer's disease.
SAGE Open Med. 2016 Jan 22;4:2050312115626731. doi: 10.1177/2050312115626731. eCollection 2016.
3
Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele.
Ann Neurol. 2002 Feb;51(2):209-14. doi: 10.1002/ana.10093.
4
Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-β in mild cognitive impairment but not in Alzheimer's disease.
J Integr Neurosci. 2021 Jun 30;20(2):277-286. doi: 10.31083/j.jin2002027.
5
Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
J Neurol Neurosurg Psychiatry. 1998 Sep;65(3):322-7. doi: 10.1136/jnnp.65.3.322.
6
Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.
J Geriatr Psychiatry Neurol. 2001 Spring;14(1):42-51. doi: 10.1177/089198870101400110.
7
Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
Brain. 2013 Jul;136(Pt 7):2201-16. doi: 10.1093/brain/awt127. Epub 2013 Jun 3.
8
Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study.
J Neurol Neurosurg Psychiatry. 2000 Jan;68(1):93-6. doi: 10.1136/jnnp.68.1.93.
9
Association of liver function markers and apolipoprotein E ε4 with pathogenesis and cognitive decline in Alzheimer's disease.
Front Aging Neurosci. 2024 Jul 24;16:1411466. doi: 10.3389/fnagi.2024.1411466. eCollection 2024.
10
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S49-S63. doi: 10.1002/alz.13403. Epub 2023 Jul 26.
本文引用的文献
1
Impact of Apolipoprotein E ε4 in Alzheimer's Disease: A Meta-Analysis of Voxel-Based Morphometry Studies.
J Clin Neurol. 2024 Sep;20(5):469-477. doi: 10.3988/jcn.2024.0176.
2
Comparing the Characteristics of Patients With Newly Diagnosed Dementia Before and After 2008 in Seoul, South Korea: A Population-Based Study.
J Clin Neurol. 2022 Nov;18(6):711-713. doi: 10.3988/jcn.2022.18.6.711.
3
[F]THK-5351 PET Patterns in Patients With Alzheimer's Disease and Negative Amyloid PET Findings.
J Clin Neurol. 2022 Jul;18(4):437-446. doi: 10.3988/jcn.2022.18.4.437.
4
Promising Blood Biomarkers for Clinical Use in Alzheimer's Disease: A Focused Update.
J Clin Neurol. 2022 Jul;18(4):401-409. doi: 10.3988/jcn.2022.18.4.401.
5
Serum neurofilament light chain level as a predictor of cognitive stage transition.
Alzheimers Res Ther. 2022 Jan 7;14(1):6. doi: 10.1186/s13195-021-00953-x.
6
Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence.
CNS Drugs. 2016 Sep;30(9):773-89. doi: 10.1007/s40263-016-0361-4.
Zotero 插件